HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivan Bogeski Selected Research

Prodrugs

1/2022Persister state-directed transitioning and vulnerability in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivan Bogeski Research Topics

Disease

11Melanoma (Melanoma, Malignant)
01/2023 - 06/2013
11Neoplasms (Cancer)
12/2022 - 06/2013
2Hypoxia (Hypoxemia)
11/2023 - 01/2016
2Prostatic Neoplasms (Prostate Cancer)
10/2015 - 11/2013
17 Hereditary Prostate Cancer
10/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
09/2023
1Autoimmune Diseases (Autoimmune Disease)
09/2023
1Neoplasm Metastasis (Metastasis)
01/2023
1Non-alcoholic Fatty Liver Disease
12/2022
1Fibrosis (Cirrhosis)
12/2022
1Inflammation (Inflammations)
12/2022
1Disease Progression
12/2022
1Ischemia
11/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Hypercholesterolemia
01/2017
1Cardiomyopathies (Cardiomyopathy)
01/2017
1Heart Failure
01/2017
1Breast Neoplasms (Breast Cancer)
01/2016
1Lymphoma (Lymphomas)
01/2015
1Pathologic Processes
10/2014

Drug/Important Bio-Agent (IBA)

5CalciumIBA
11/2022 - 05/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 10/2014
3Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2021
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2019
2Transcription Factors (Transcription Factor)IBA
11/2023 - 12/2022
2EnzymesIBA
12/2022 - 06/2013
2mitochondrial calcium uniporterIBA
01/2018 - 01/2016
2Messenger RNA (mRNA)IBA
01/2016 - 11/2013
1Oxygen (Dioxygen)IBA
11/2023
1SodiumIBA
10/2023
1AntigensIBA
12/2022
1InflammasomesIBA
12/2022
1ursodoxicoltaurineIBA
12/2022
1Proto-Oncogene Proteins B-rafIBA
11/2022
1AntioxidantsIBA
11/2022
11,4-dihydropyridine (dihydropyridine)IBA
01/2022
1PlasticsIBA
01/2022
1Folic Acid AntagonistsIBA
01/2022
1ProdrugsIBA
01/2022
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2021
1MicroRNAs (MicroRNA)IBA
10/2021
1GemcitabineFDA Link
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2019
1CholesterolIBA
01/2017
1Metoprolol (Toprol-XL)FDA LinkGeneric
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1PerhexilineIBA
01/2017
1Phytosterols (Plant Sterols)IBA
01/2017
1MargarineIBA
01/2017
1EstersIBA
01/2017
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2017
1Fatty Acids (Saturated Fatty Acids)IBA
01/2017
1DobutamineFDA LinkGeneric
01/2017
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2017
1etomoxirIBA
01/2017
1CytokinesIBA
01/2016
1Calcium Channels (Calcium Channel)IBA
01/2016
1elesclomolIBA
02/2015
1Polystyrenes (Polystyrene)IBA
01/2015
1Microphthalmia-Associated Transcription FactorIBA
05/2014
1Small Interfering RNA (siRNA)IBA
11/2013
1Androgen Receptors (Androgen Receptor)IBA
11/2013
1Calcium Release Activated Calcium ChannelsIBA
11/2013
1AndrogensIBA
11/2013
1ProteomeIBA
06/2013
1Adenosine Triphosphate (ATP)IBA
06/2013
1VemurafenibIBA
06/2013
1Antineoplastic Agents (Antineoplastics)IBA
06/2013
1Cisplatin (Platino)FDA LinkGeneric
06/2013

Therapy/Procedure

9Therapeutics
09/2023 - 06/2013
2Immunotherapy
11/2022 - 11/2021
1Photopheresis
09/2023